You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Infiltrating macrophages

Showing 1 - 25 of 848
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer Trial in Saint Louis (drug, biological, procedure)

Recruiting
  • Triple Negative Breast Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 19, 2022

Low-grade Oral Dysplasia Trial in Boston (Probiotic oral lozenges, Standard of care for oral dysplasia)

Not yet recruiting
  • Low-grade Oral Dysplasia
  • Probiotic oral lozenges
  • Standard of care for oral dysplasia
  • Boston, Massachusetts
    Boston Medical Center
Jan 22, 2023

Measuring Active Microglia in Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
  • [C11]PK-1195 PET scan
  • New York, New York
    Weill Cornell Medical College
Jan 14, 2022

Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • +2 more
  • Ferumoxytol infusion
  • +2 more
  • Salt Lake City, Utah
    University of Utah Health Imaging and Neurosciences Center
Jun 22, 2022

Abdominal Aortic Aneurysm Trial (Evolocumab, Placebo)

Not yet recruiting
  • Abdominal Aortic Aneurysm
  • (no location specified)
Oct 12, 2023

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Glioblastoma Multiforme, Glioblastoma, Adult, Glioma of Brain Trial in Geneva (IMA950/Poly-ICLC, IMA950/Poly-ICLC and

Active, not recruiting
  • Glioblastoma Multiforme
  • +3 more
  • Geneva, Switzerland
    University Hospitals of Geneva
Dec 23, 2022

Colorectal Cancer, ADCC Trial in Napoli (Folfiri/Cetuximab)

Recruiting
  • Colorectal Cancer
  • ADCC
  • Napoli, Italy
    Istituto Nazionale dei Tumori,
Sep 1, 2021

Metastatic Large Cell Neuroendocrine Carcinoma, Metastatic Neuroendocrine Carcinoma, Metastatic Neuroendocrine Tumor Trial in

Active, not recruiting
  • Metastatic Large Cell Neuroendocrine Carcinoma
  • +3 more
  • Cabozantinib S-malate
  • +2 more
  • Birmingham, Alabama
  • +46 more
Dec 30, 2022

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Melanoma Trial in Lausanne (Tc-99m tilmanocept)

Recruiting
  • Melanoma
  • Tc-99m tilmanocept
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois
Jun 11, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Atezolizumab
  • +5 more
  • (no location specified)
Feb 4, 2023

Cachexia, Muscle Loss, Muscle Wasting Trial in Hasselt (Muscle Biopsy)

Completed
  • Cachexia
  • +4 more
  • Muscle Biopsy
  • Hasselt, Belgium
    Jessa Ziekenhuis
Jul 7, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Immune Checkpoint Inhibitors in Genitourinary Malignancies

Suspended
  • Carcinoma, Renal Cell
  • Carcinoma, Urothelial
  • Immune cell and CTC detection procedures
  • Durham, North Carolina
    Duke University Medical Center
Nov 11, 2022

Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts

Recruiting
  • Pancreas Adenocarcinoma
  • Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
  • Suwon, Gyeong Gi Do, Korea, Republic of
    Ajou University Hospital
Oct 7, 2022

PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

Not yet recruiting
  • PD-1 Refractory Advanced Melanoma
  • Responder-Derived Fecal microbiota transplantation (R-FMT
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 1, 2023

Pancreatic Adenocarcinoma Trial in Stanford (ExAblate 2100)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • ExAblate 2100
  • Stanford, California
    Stanford Cancer Center
Oct 25, 2022

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Breast Tumors Trial in Roma, Rome (Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES))

Recruiting
  • Breast Neoplasms
  • Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES)
  • Roma, Italy
  • +1 more
Mar 29, 2023

Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
  • VLP-encapsulated TLR9 Agonist CMP-001
  • Scottsdale, Arizona
  • +3 more
Jun 1, 2022

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial in Tianjin (LM103)

Recruiting
  • Solid Tumor
  • LM103
  • Tianjin, China
    Tianjin Beichen Hospital
Jul 4, 2023

Immune Checkpoints in Intraabdominal Ascites Fluid

Completed
  • Colorectal Cancer
  • Flow-cytometric analysis
  • Istanbul, Turkey
    Ufuk Oguz Idiz
Dec 4, 2022